[HTML][HTML] Liquid biopsy in gastric cancer: predictive and prognostic biomarkers

Z Zhang, H Wu, W Chong, L Shang, C Jing, L Li - Cell death & disease, 2022 - nature.com
Gastric cancer (GC) is a high-incidence cancer worldwide. Most patients are diagnosed at
an advanced stage, by which time they have limited treatment options and poor prognosis …

[HTML][HTML] A Circular RNAs: Emerging roles and new insights in human cancers

Z He, Q Zhu - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Circular RNAs (circRNAs) are single-stranded, covalently closed RNA molecules formed by
mRNA exon back-splicing. Although the circRNA functions remain largely unknown, their …

[HTML][HTML] Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer

H Shen, Y Jin, H Zhao, M Wu, K Zhang, Z Wei, X Wang… - BMC medicine, 2022 - Springer
Background Liquid biopsy has been widely researched for early diagnosis, prognostication
and disease monitoring in lung cancer, but there is a need to investigate its clinical utility for …

Exosomal circRNAs in cancer: implications for therapy resistance and biomarkers

Z Lin, Y Ji, J Zhou, G Li, Y Wu, W Liu, Z Li, T Liu - Cancer Letters, 2023 - Elsevier
Despite the advances in cancer treatment in recent years, the development of resistance to
cancer therapy remains the biggest hurdle towards curative cancer treatments. Therefore …

[HTML][HTML] Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer

V Caputo, F Ciardiello, CM Della Corte… - … of targeted anti-tumor …, 2023 - ncbi.nlm.nih.gov
Liquid biopsy is a diagnostic repeatable test, which in last years has emerged as a powerful
tool for profiling cancer genomes in real-time with minimal invasiveness and tailoring …

[HTML][HTML] The role of circulating biomarkers in lung cancer

S Herath, H Sadeghi Rad, P Radfar, R Ladwa… - Frontiers in …, 2022 - frontiersin.org
Lung cancer is the leading cause of cancer morbidity and mortality worldwide and early
diagnosis is crucial for the management and treatment of this disease. Non-invasive means …

[HTML][HTML] Advancements in the diagnosis of hepatocellular carcinoma

NS Parra, HM Ross, A Khan, M Wu, R Goldberg… - International Journal of …, 2023 - mdpi.com
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy, with
increasing global incidence. Morbidity and mortality associated with HCC remains high, and …

[HTML][HTML] Liquid biopsy in early-stage lung cancer: Current and Future Clinical Applications

O Vandekerckhove, K Cuppens, K Pat, B Du Pont… - Cancers, 2023 - mdpi.com
Simple Summary Early-stage disease non-small cell lung cancer has better outcomes than
advanced disease, but 5-year survival rates can drop to approximately 50% in cases of …

[HTML][HTML] The role of cell-free DNA in cancer treatment decision making

A Telekes, A Horváth - Cancers, 2022 - mdpi.com
Simple Summary The aim of this review is to evaluate the present status of the use of cell-
free DNA and its fraction of circulating tumor DNA (ctDNA) because this year July 2022, an …

[HTML][HTML] Landscape of innovative methods for early diagnosis of gastric cancer: a systematic review

A Orășeanu, MC Brisc, OA Maghiar, H Popa, CM Brisc… - Diagnostics, 2023 - mdpi.com
From a global perspective, gastric cancer (GC) persists as a significant healthcare issue. In
the Western world, the majority of cases are discovered at late stages, when the treatment is …